title: Cardiac autonomic nervous system activity in obesity.
abstract: The development of obesity is caused by a disturbance of energy balance, with energy intake exceeding energy expenditure. As the autonomic nervous system (ANS) has a role in the regulation of both these variables, it has become a major focus of investigation in the fields of obesity pathogenesis. The enhanced cardiac sympathetic drive shown in most of the studies in obese persons might be due to an increase in their levels of circulating insulin. The role of leptin needs further investigation with studies in humans. There is a blunted response of the cardiac sympathetic nervous system (SNS) activity in obese subjects after consumption of a carbohydrate-rich meal as well as after insulin administration. This might be due to insulin resistance. It is speculated that increased SNS activity in obesity may contribute to the development of hypertension in genetically susceptible individuals. It is also speculated that the increase in cardiac SNS activity under fasting conditions in obesity may be associated with high cardiovascular morbidity and mortality.
authors.affiliation: 1st Department of Propaedeutic Medicine, Athens University Medical School, Laiko General Hospital, Athens, Greece.
authors.forename: Stavros
authors.initials: S
authors.lastname: Liatis
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Tentolouris
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Katsilambros
mesh_terms: D001341:Autonomic Nervous System / Q000378:metabolism / Q000503:physiopathology*; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D006321:Heart / Q000294:innervation*; D006801:Humans; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood; D009638:Norepinephrine / Q000097:blood; D009765:Obesity / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D012307:Risk Factors
chemical_list: D007328:Insulin; D020738:Leptin; D009638:Norepinephrine